miRNAs in B Cell Development and Lymphomagenesis

Trends in Molecular Medicine

Volumn 23, Issue 8, 2017, Pages 721-736

  Coffre, Maryaline ^a   Koralov, Sergei B ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

B cell development; B cell function; B cell lymphomas; miRNAs

Indexed keywords

MICRORNA; MICRORNA 126; MICRORNA 132; MICRORNA 148A; MICRORNA 150; MICRORNA 155; MICRORNA 17; MICRORNA 181B; MICRORNA 185; MICRORNA 23A; MICRORNA 34; MICRORNA 92; UNCLASSIFIED DRUG; RNA;

B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; B LYMPHOCYTE DIFFERENTIATION; CELL CYCLE REGULATION; CELL MATURATION; GENE CONTROL; GENE EXPRESSION; GENETIC VARIABILITY; HUMAN; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE TRANSFORMATION; LYMPHOMAGENESIS; MALIGNANT TRANSFORMATION; NONHUMAN; PRE B LYMPHOCYTE; REVIEW; TARGET CELL; ANIMAL; B CELL LYMPHOMA; CELL TRANSFORMATION; METABOLISM; PATHOLOGY;

ANIMALS; B-LYMPHOCYTES; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; LYMPHOMA, B-CELL; MICRORNAS; RNA, NEOPLASM;

EID: 85021855835     PISSN: 14714914     EISSN: 1471499X     Source Type: Journal    
DOI: 10.1016/j.molmed.2017.06.001     Document Type: Review

References (93)

1. Fabian, M.R., Sonenberg, N., The mechanics of miRNA-mediated gene silencing: a look under the hood of miRISC. Nat. Struct. Mol. Biol. 19 (2012), 586–593.
2. Ha, M., Kim, V.N., Regulation of microRNA biogenesis. Nat. Rev. Mol. Cell Biol. 15 (2014), 509–524.
3. Lee, R.C., et al. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75 (1993), 843–854.
4. Wightman, B., et al. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 75 (1993), 855–862.
5. Lagos-Quintana, M., et al. Identification of novel genes coding for small expressed RNAs. Science 294 (2001), 853–858.
6. Lau, N.C., et al. An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science 294 (2001), 858–862.
7. Lee, R.C., Ambros, V., An extensive class of small RNAs in Caenorhabditis elegans. Science 294 (2001), 862–864.
8. Rajewsky, K., Clonal selection and learning in the antibody system. Nature 381 (1996), 751–758.
9. Hwang, J.K., et al. Related mechanisms of antibody somatic hypermutation and class switch recombination. Microbiol. Spectr., 3, 2015 Mdna3-0037-2014.
10. Baek, D., et al. The impact of microRNAs on protein output. Nature 455 (2008), 64–71.
11. Basso, K., et al. Identification of the human mature B cell miRNome. Immunity 30 (2009), 744–752.
12. Chen, C.Z., et al. MicroRNAs modulate hematopoietic lineage differentiation. Science 303 (2004), 83–86.
13. Kuchen, S., et al. Regulation of microRNA expression and abundance during lymphopoiesis. Immunity 32 (2010), 828–839.
14. Landgraf, P., et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129 (2007), 1401–1414.
15. Spierings, D.C., et al. Ordered progression of stage-specific miRNA profiles in the mouse B2 B-cell lineage. Blood 117 (2011), 5340–5349.
16. Zhang, J., et al. Patterns of microRNA expression characterize stages of human B-cell differentiation. Blood 113 (2009), 4586–4594.
17. Pritchard, C.C., et al. MicroRNA profiling: approaches and considerations. Nat. Rev. Genet. 13 (2012), 358–369.
18. Svoboda, P., A toolbox for miRNA analysis. FEBS Lett. 589 (2015), 1694–1701.
19. Nutt, S.L., Kee, B.L., The transcriptional regulation of B cell lineage commitment. Immunity 26 (2007), 715–725.
20. Hystad, M.E., et al. Characterization of early stages of human B cell development by gene expression profiling. J. Immunol. 179 (2007), 3662–3671.
21. Nutt, S.L., et al. The generation of antibody-secreting plasma cells. Nat. Rev. Immunol. 15 (2015), 160–171.
22. Fragoso, R., et al. Modulating the strength and threshold of NOTCH oncogenic signals by mir-181a-1/b-1. PLoS Genet., 8, 2012, e1002855.
23. Henao-Mejia, J., et al. The microRNA miR-181 is a critical cellular metabolic rheostat essential for NKT cell ontogenesis and lymphocyte development and homeostasis. Immunity 38 (2013), 984–997.
24. Okuyama, K., et al. MicroRNA-126-mediated control of cell fate in B-cell myeloid progenitors as a potential alternative to transcriptional factors. Proc. Natl. Acad. Sci. U. S. A. 110 (2013), 13410–13415.
25. Kong, K.Y., et al. MiR-23A microRNA cluster inhibits B-cell development. Exp. Hematol. 38 (2010), 629–640.
26. Mehta, A., et al. The microRNA-212/132 cluster regulates B cell development by targeting Sox4. J. Exp. Med. 212 (2015), 1679–1692.
27. Koralov, S.B., et al. Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage. Cell 132 (2008), 860–874.
28. Coffre, M., et al. miRNAs are essential for the regulation of the PI3K/AKT/FOXO pathway and receptor editing during B cell maturation. Cell Rep. 17 (2016), 2271–2285.
29. Brandl, A., et al. The microprocessor component, DGCR8, is essential for early B-cell development in mice. Eur. J. Immunol. 46 (2016), 2710–2718.
30. Ventura, A., et al. Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell 132 (2008), 875–886.
31. Lai, M., et al. Regulation of B-cell development and tolerance by different members of the miR-17 approximately 92 family microRNAs. Nat. Commun., 7, 2016, 12207.
32. Xiao, C., et al. MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell 131 (2007), 146–159.
33. Zhou, B., et al. miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely. Proc. Natl. Acad. Sci. U. S. A. 104 (2007), 7080–7085.
34. Rao, D.S., et al. MicroRNA-34a perturbs B lymphocyte development by repressing the forkhead box transcription factor Foxp1. Immunity 33 (2010), 48–59.
35. Hu, H., et al. Foxp1 is an essential transcriptional regulator of B cell development. Nat. Immunol. 7 (2006), 819–826.
36. Pelanda, R., Torres, R.M., Central B-cell tolerance: where selection begins. Cold Spring Harb. Perspect. Biol., 4, 2012, a007146.
37. Duong, B.H., et al. Negative selection by IgM superantigen defines a B cell central tolerance compartment and reveals mutations allowing escape. J. Immunol. 187 (2011), 5596–5605.
38. Werner, M., et al. Role of PI3K in the generation and survival of B cells. Immunol. Rev. 237 (2010), 55–71.
39. Chung, J.B., et al. Transitional B cells: step by step towards immune competence. Trends Immunol. 24 (2003), 343–349.
40. Benhamou, D., et al. A c-Myc/miR17-92/Pten axis controls PI3K-mediated positive and negative selection in B cell development and reconstitutes CD19 deficiency. Cell Rep. 16 (2016), 419–431.
41. Diamant, E., et al. CD19 regulates positive selection and maturation in B lymphopoiesis: lack of CD19 imposes developmental arrest of immature B cells and consequential stimulation of receptor editing. Blood 105 (2005), 3247–3254.
42. Gonzalez-Martin, A., et al. The microRNA miR-148a functions as a critical regulator of B cell tolerance and autoimmunity. Nat. Immunol. 17 (2016), 433–440.
43. Salvador, J.M., et al. The autoimmune suppressor Gadd45alpha inhibits the T cell alternative p38 activation pathway. Nat. Immunol. 6 (2005), 396–402.
44. Nemazee, D., Receptor editing in lymphocyte development and central tolerance. Nat. Rev. Immunol. 6 (2006), 728–740.
45. Deriano, L., et al. The RAG2C terminus suppresses genomic instability and lymphomagenesis. Nature 471 (2011), 119–123.
46. Mills, K.D., et al. The role of DNA breaks in genomic instability and tumorigenesis. Immunol. Rev. 194 (2003), 77–95.
47. Belver, L., et al. MicroRNAs prevent the generation of autoreactive antibodies. Immunity 33 (2010), 713–722.
48. Pillai, S., Cariappa, A., The follicular versus marginal zone B lymphocyte cell fate decision. Nat. Rev. Immunol. 9 (2009), 767–777.
49. Tarlinton, D., Good-Jacobson, K., Diversity among memory B cells: origin, consequences, and utility. Science 341 (2013), 1205–1211.
50. Keim, C., et al. Regulation of AID, the B-cell genome mutator. Genes Dev. 27 (2013), 1–17.
51. Xu, S., et al. The RNase III enzyme Dicer is essential for germinal center B-cell formation. Blood 119 (2012), 767–776.
52. Rodriguez, A., et al. Requirement of bic/microRNA-155 for normal immune function. Science 316 (2007), 608–611.
53. Thai, T.H., et al. Regulation of the germinal center response by microRNA-155. Science 316 (2007), 604–608.
54. Vigorito, E., et al. microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells. Immunity 27 (2007), 847–859.
55. Houston, I.B., et al. Reduction in PU.1 activity results in a block to B-cell development, abnormal myeloid proliferation, and neonatal lethality. Exp. Hematol. 35 (2007), 1056–1068.
56. Lu, D., et al. The miR-155–PU.1 axis acts on Pax5 to enable efficient terminal B cell differentiation. J. Exp. Med. 211 (2014), 2183–2198.
57. Alivernini, S., et al. MicroRNA-155 influences B-cell function through PU.1 in rheumatoid arthritis. Nat. Commun., 7, 2016, 12970.
58. Dorsett, Y., et al. MicroRNA-155 suppresses activation-induced cytidine deaminase-mediated Myc–IgH translocation. Immunity 28 (2008), 630–638.
59. Teng, G., et al. MicroRNA-155 is a negative regulator of activation-induced cytidine deaminase. Immunity 28 (2008), 621–629.
60. Dorsett, Y., et al. A role for AID in chromosome translocations between c-myc and the IgH variable region. J. Exp. Med. 204 (2007), 2225–2232.
61. de Yebenes, V.G., et al. miR-181b negatively regulates activation-induced cytidine deaminase in B cells. J. Exp. Med. 205 (2008), 2199–2206.
62. Xu, S., et al. Mir-17-92 regulates bone marrow homing of plasma cells and production of immunoglobulin G2c. Nat. Commun., 6, 2015, 6764.
63. Kabashima, K., et al. Plasma cell S1P1 expression determines secondary lymphoid organ retention versus bone marrow tropism. J. Exp. Med. 203 (2006), 2683–2690.
64. Minges Wols, H.A., et al. The role of bone marrow-derived stromal cells in the maintenance of plasma cell longevity. J. Immunol. 169 (2002), 4213–4221.
65. Baumgarth, N., The double life of a B-1 cell: self-reactivity selects for protective effector functions. Nat. Rev. Immunol. 11 (2011), 34–46.
66. −. J. Exp. Med. 208 (2011), 67–80.
67. Hayakawa, K., et al. Early generated B1 B cells with restricted BCRs become chronic lymphocytic leukemia with continued c-Myc and low Bmf expression. J. Exp. Med. 213 (2016), 3007–3024.
68. Kristiansen, T.A., et al. Cellular barcoding links B-1a B cell potential to a fetal hematopoietic stem cell state at the single-cell level. Immunity 45 (2016), 346–357.
69. Yuan, J., et al. Lin28b reprograms adult bone marrow hematopoietic progenitors to mediate fetal-like lymphopoiesis. Science 335 (2012), 1195–1200.
70. Zhou, Y., et al. Lin28b promotes fetal B lymphopoiesis through the transcription factor Arid3a. J. Exp. Med. 212 (2015), 569–580.
71. Schmidt, C., et al. Signalling of the BCR is regulated by a lipid rafts-localised transcription factor Bright. EMBO J. 28 (2009), 711–724.
72. Xiao, C., et al. Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat. Immunol. 9 (2008), 405–414.
73. Anzelon, A.N., et al. Pten inactivation alters peripheral B lymphocyte fate and reconstitutes CD19 function. Nat. Immunol. 4 (2003), 287–294.
74. Rickert, R.C., et al. Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice. Nature 376 (1995), 352–355.
75. Lu, J., et al. MicroRNA expression profiles classify human cancers. Nature 435 (2005), 834–838.
76. Thomson, J.M., et al. Extensive post-transcriptional regulation of microRNAs and its implications for cancer. Genes Dev. 20 (2006), 2202–2207.
77. Calin, G.A., et al. MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc. Natl. Acad. Sci. U. S. A. 101 (2004), 11755–11760.
78. Cui, B., et al. MicroRNA-155 influences B-cell receptor signaling and associates with aggressive disease in chronic lymphocytic leukemia. Blood 124 (2014), 546–554.
79. Danielson, L.S., et al. Limited miR-17-92 overexpression drives hematologic malignancies. Leuk. Res. 39 (2015), 335–341.
80. Eis, P.S., et al. Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc. Natl. Acad. Sci. U. S. A. 102 (2005), 3627–3632.
81. He, L., et al. A microRNA polycistron as a potential human oncogene. Nature 435 (2005), 828–833.
82. Jin, H.Y., et al. MicroRNA-17∼92 plays a causative role in lymphomagenesis by coordinating multiple oncogenic pathways. EMBO J. 32 (2013), 2377–2391.
83. Lawrie, C.H., et al. MicroRNA expression in lymphocyte development and malignancy. Leukemia 22 (2008), 1440–1446.
84. Mu, P., et al. Genetic dissection of the miR-17∼92 cluster of microRNAs in Myc-induced B-cell lymphomas. Genes Dev. 23 (2009), 2806–2811.
85. Nucera, S., et al. miRNA-126 orchestrates an oncogenic program in B cell precursor acute lymphoblastic leukemia. Cancer Cell 29 (2016), 905–921.
86. Pede, V., et al. CLL cells respond to B-cell receptor stimulation with a microRNA/mRNA signature associated with MYC activation and cell cycle progression. PLoS One, 8, 2013, e60275.
87. Sandhu, S.K., et al. B-cell malignancies in microRNA Emu–miR-17∼92 transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 110 (2013), 18208–18213.
88. Tavolaro, S., et al. Increased chronic lymphocytic leukemia proliferation upon IgM stimulation is sustained by the upregulation of miR-132 and miR-212. Genes Chromosomes Cancer 54 (2015), 222–234.
89. Ota, A., et al. Identification and characterization of a novel gene, C13orf25, as a target for 13q31–q32 amplification in malignant lymphoma. Cancer Res. 64 (2004), 3087–3095.
90. Adams, J.M., et al. The c-Myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature 318 (1985), 533–538.
91. Craig, V.J., et al. Myc-mediated repression of microRNA-34a promotes high-grade transformation of B-cell lymphoma by dysregulation of FoxP1. Blood 117 (2011), 6227–6236.
92. Craig, V.J., et al. Systemic microRNA-34a delivery induces apoptosis and abrogates growth of diffuse large B-cell lymphoma in vivo. Leukemia 26 (2012), 2421–2424.
93. Staudt, L.M., Dave, S., The biology of human lymphoid malignancies revealed by gene expression profiling. Adv. Immunol. 87 (2005), 163–208.